定量PCR-Taqman探针法检测NS0宿主细胞残留DNA的方法学验证

武刚, 付志浩, 杨志行, 崔永霏, 张荣建, 宗伟英, 王兰

中国药学杂志 ›› 2019, Vol. 54 ›› Issue (24) : 2001-2009.

PDF(3722 KB)
PDF(3722 KB)
中国药学杂志 ›› 2019, Vol. 54 ›› Issue (24) : 2001-2009. DOI: 10.11669/cpj.2019.24.001
单克隆抗体药物分析方法验证专栏

定量PCR-Taqman探针法检测NS0宿主细胞残留DNA的方法学验证

  • 武刚1, 付志浩1, 杨志行2, 崔永霏1, 张荣建1, 宗伟英2, 王兰1*
作者信息 +

Validation of Quantitative PCR-Taqman Probe Method for Detection of Residual NS0 Host Cell DNA

  • WU Gang1, FU Zhi-hao1, YANG Zhi-xing2, CUI Yong-fei1, ZHANG Rong-jian1, ZONG Wei-ying2, WANG Lan1*
Author information +
文章历史 +

摘要

目的 NS0宿主细胞残留DNA检测(定量PCR-Taqman探针法)方法的验证。方法 针对小鼠骨髓瘤细胞(NS0)基因组重复序列设计合成多对引物、探针,通过实验优选最佳的引物探针组合;应用所建立的前处理试剂盒(磁珠法)对供试品中宿主细胞残留DNA进行富集纯化;根据《国际人用药品注册技术协调会(ICH)》及《中国药典》通则9101的要求,应用所建立的NS0宿主细胞DNA残留检测试剂盒进行线性与范围、准确度、精密度、专属性、定量限的方法学验证。应用NS0细胞生产的单克隆抗体工艺中间品及原液,验证所建立试剂盒对实际生产样品的检测性能,并组织5个独立实验室进行协作标定。结果 NS0细胞DNA检测(Taqman法)正向引物序列: CCCCTTCAGCTCCTTGGGTA、反向引物序列:GCCTGGCAAATACAGAAGTGG、荧光探针序列: FAM-AGGGCCCCCAATGGAGGAGCT-TAMRA;NS0细胞DNA标准曲线在3 fg·μL-1~300 pg·μL-1内,线性良好(r2>0.99);对6个浓度梯度检测的准确度偏差均<15%;定量限为3 fg·μL-1;内部参考品 DNA 标定结果为30 μg·mL-1;精密度良好(RSD≤30%);能特异性地检测NS0细胞DNA,对大肠杆菌DNA、人类基因组 DNA(人肾上皮293T细胞)、CHO(中国仓鼠卵巢)细胞DNA无扩增反应。另外,对于生产工艺中间品及原液的检测回收率均在70%~130%,RSD均<15%。5个独立实验室间协标检测数据RSD均<30%。结论 自主研发NS0宿主细胞DNA残留检测试剂盒(定量PCR-Taqman探针法)特异性强、灵敏度高、准确度好,能够满足NS0宿主 DNA 残留检测要求。

Abstract

OBJECTIVE To validate a PCR-Taqman probe method for detection of residual DNA of NS0 host cells. METHODS Multiple pairs of primers and probes were designed and synthesized for the NS0 genome repeat sequence, and the optimal primer probe combination was selected through experiments. Pretreatment kit (magnetic bead method) was used to enrich and purify the host cell DNA residue in the sample.According to the requirements of ICH and China Pharmacopoeia general principle No. 9101, validation of the detection method including linearity and range, accuracy,precision, specificity, quantitative limit and reference DNA calibration was carried out for self-developed residual CHO host cell DNA quantitation kit (PCR-Taqman probe).Using the intermediate product and drug substance of the monoclonal antibody process produced by NS0 cells, the test performance of the kit was verified, and five independent laboratories were organized to coordinate the calibration. RESULTS NS0 cell DNA detection (Taqman method) forward primer sequence was CCCCTTCAGCTCCTTGGGTA, reverse primer sequence was GCCTGGCAAATACAGAAGTGG, and probe sequence was FAM-AGGGCCCCCAATGGAGGAGCT-TAMRA. The standard curve of DNA was in the range of 3 fg·μL-1 to 300 pg·μL-1 with good linearity (r2>0. 99). The deviation of the mean from the true value was less than 15% at six different concentrations. The quantitative limit was 3 fg·μL-1.The DNA calibration result of the internal reference sample was 30 μg·mL-1. Good precision (RSD≤30%) was obtained. The q-PCR method was specific for CHO DNA,which showed no responses to the DNA of E. coli, human genome DNA(kidney epithelium 293T cells), and CHO genome DNA(Chinese hamster ovary cells). In addition, the detection recovery rate was in the range of 70% to 130% with RSD less than 15% for the intermediate products and drug substance in the production process. The RSD of the five collaborative laboratories was less than 30%. CONCLUSION The self-developed residual NS0 host cell DNA quantitation kit (PCR-Taqman probe) has good specificity, sensitivity and accuracy,and can meet the requirements of host DNA residue detection.

关键词

NS0 DNA标准品 / NS0 宿主细胞DNA残留检测 / PCR-Taqman探针法 / 方法验证

Key words

NS0 DNA standard product / NS0 host cell DNA residue detection / PCR-Taqman probe method / PCR-Taqman probe / method validation

引用本文

导出引用
武刚, 付志浩, 杨志行, 崔永霏, 张荣建, 宗伟英, 王兰. 定量PCR-Taqman探针法检测NS0宿主细胞残留DNA的方法学验证[J]. 中国药学杂志, 2019, 54(24): 2001-2009 https://doi.org/10.11669/cpj.2019.24.001
WU Gang, FU Zhi-hao, YANG Zhi-xing, CUI Yong-fei, ZHANG Rong-jian, ZONG Wei-ying, WANG Lan. Validation of Quantitative PCR-Taqman Probe Method for Detection of Residual NS0 Host Cell DNA[J]. Chinese Pharmaceutical Journal, 2019, 54(24): 2001-2009 https://doi.org/10.11669/cpj.2019.24.001
中图分类号: R917   

参考文献

[1] YANG H, WEI Z, SCHENERMAN M. A statistical approach to determining criticality of residual host cell DNA[J]. Biopharm Stat,2015, 25(2):234-246.
[2] Food and Drug Administration (FDA) . Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use, Food and Drug Administration, Center for BiologicsEvaluation and Research[EB/OL]. 1997, [2019-06-18]. https://www.fda.gov/media/76798/download.
[3] World Health Organization (WHO). WHO Expert Committee on Biological Standardization. Highlights of the 46th meeting, October 1996 [J]. Wkly Epidemiol Rec, 1997, 72(20): 141-145.
[4] DHARA V G, NAIK H M, MAJEWSKANI. Recombinant antibody production in CHO and NS0 cells: differences and similaritie[J]. Bio Drugs, 2018, 6(32):571-584.
[5] Ch.P(2015).Vol Ⅲ(中国药典2015年版. 三部)[S]. 2015:363-365, General Principle 9101.
[6] RIAHI F, DERAKHSHAN M, MOSAVAT A, et al. Evaluation of point mutation detection in Mycobacterium tuberculosis with isoniazid resistance using real-time PCR and TaqMan probe assay[J]. Appl Biochem Biotechnol, 2015,175(5):2447-2455.
[7] CHANG J T, CHEN Y C, CHOU Y C, et al. Quantitative detection of residual porcine host cell DNA by real-time PCR[J]. Biologicals, 2014,42(2):74-78.
[8] USP. In-process revision: general chapters〈509〉residual DNA testing.PF Online[S].2016.
[9] ICH. Harmonized tripartite guideline: validation of analytical procedures: text and methodology Q2(R1) [S]. 2005: 11.
[10] HUSSAIN M. A direct qPCR method for residual DNA quantification in monoclonalantibody drugs produced in CHO cells [J]. J Pharm Biomed Anal, 2015, 115:603-606.
[11] SOMMERS C, ROSENZWEIG B, OUML, et al. Quantitation of residual host cell DNA in protaminesulfate drug product by qPCR [J]. Pharm Biomed Anal,2018,160(25):238-243.

基金

国家“重大新药创制”科技重大专项项目资助(2018ZX09736008);中国医学医科院-中央级公益性科研院所基本科研业务费专项课题项目资助(2017PT31041)

PDF(3722 KB)

Accesses

Citation

Detail

段落导航
相关文章

/